eHEALTH BureauBiocon, India’s largest biotechnology company, entered into an agreement with Teleradiology Solutions, a pioneer of the domain in India, to provide teleradiology reporting services to Clinigene, Biocon’s Clinical Research Organisation. Teleradiology Solution’s quality-driven reporting process and cutting-edge technology platform have the potential to greatly benefit biotech and pharma companies, obviating delays in the completion of clinical trials by optimising the radiology reporting process. Teleradiology Solutions offers pharmaceutical vendors, clinical research organisations, and biotechnology organisations the opportunity to shorten their development cycles by using TRS Clinical Trials Radiology Reporting service. The organisation offers quality reporting by radiologists experienced in Response uation Criteria In Solid Tumors (RECIST) and World Health Organisation (WHO) measurement criteria.According to Kiran Mazumdar Shaw, Chairman & Managing Director of Biocon, “To achieve our main objective, Accelerating Clinical Research, we leverage on an adept mix of technology, experience and personal traits. Keeping in line with our mission, Teleradiology Solutions, given their impressive track record, was the partner of choice to meet our complex image analysis requirements.”Further to that, Dr Arjun Kalyanpur, MD and Chief Radiologists, Teleradiology Solutions commented, “For pharmaceutical and Biotechnology companies involved in drug development R&D, delays in the drug development cycle can be an issue of concern. We are happy to partner with Biocon and offer our services to ensure timely ution and quality uation for clinical trials in radiology.”

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.